Applied DNA Sciences (NASDAQ: APDN) reported Q3 EPS of ($0.24), in-line with the analyst estimate of ($0.24). Revenue for the quarter came in at $2.92 million versus the consensus estimate of $2.56 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.